Ascentage Pharma Group Stock Price Patterns

Intrinsic Valuation Low Real High 21.25 28.75 32.23 Details

2 Analysts Consensus Low Target High 41.60 45.71 50.74 Details

Earnings Estimates (0) Low Projected EPS High -0.63 -0.35 -0.1 Details

Ascentage Pharma After-Hype Price Density Analysis

Ascentage Pharma Estimiated After-Hype Price Volatility

Ascentage Pharma Stock Price Outlook Analysis

Notes

Ascentage Pharma Hype Timeline

Ascentage Pharma is presently traded for 23.61. The entity has historical hype elasticity of 0.33, and average elasticity to hype of competition of -0.2. Ascentage is projected to increase in value after the next headline, with the price projected to jump to 23.94 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 1.4%, whereas the daily expected return is presently at -0.49%. The volatility of related hype on Ascentage Pharma is about 834.53%, with the expected price after the next announcement by competition of 23.41. The company reported the previous year's revenue of 980.65 M. Net Loss for the year was (395.25 M) with profit before overhead, payroll, taxes, and interest of 354.93 M. Given the investment horizon of 90 days the next projected press release will be in about 9 days. Check out Ascentage Pharma Basic Forecasting Models to cross-verify your projections.

Ascentage Pharma Related Hype Analysis

Ascentage Pharma Additional Predictive Modules

Most predictive techniques to examine Ascentage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Ascentage using various technical indicators. When you analyze Ascentage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Ascentage Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Ascentage Pharma Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Ascentage Pharma based on analysis of Ascentage Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.

When running Ascentage Pharma's price analysis, check to measure Ascentage Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascentage Pharma is operating at the current time. Most of Ascentage Pharma's value examination focuses on studying past and present price action to predict the probability of Ascentage Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascentage Pharma's price. Additionally, you may evaluate how the addition of Ascentage Pharma to your portfolios can decrease your overall portfolio volatility.